Premium
Androgen receptor‐related diseases: what do we know?
Author(s) -
Shukla G. C.,
Plaga A. R.,
Shankar E.,
Gupta S.
Publication year - 2016
Publication title -
andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 43
eISSN - 2047-2927
pISSN - 2047-2919
DOI - 10.1111/andr.12167
Subject(s) - androgen receptor , transactivation , prostate cancer , spinal and bulbar muscular atrophy , sexual function , androgen insensitivity syndrome , androgen , hyperplasia , prostate , biology , complete androgen insensitivity syndrome , medicine , cancer research , endocrinology , cancer , bioinformatics , transcription factor , genetics , hormone , gene
Summary The androgen receptor ( AR ) and the androgen– AR signaling pathway play a significant role in male sexual differentiation and the development and function of male reproductive and non‐reproductive organs. Because of AR 's widely varied and important roles, its abnormalities have been identified in various diseases such as androgen insensitivity syndrome, spinal bulbar muscular atrophy, benign prostatic hyperplasia, and prostate cancer. This review provides an overview of the function of androgens and androgen– AR mediated diseases. In addition, the diseases delineated above are discussed with respect to their association with mutations and other post‐transcriptional modifications in the AR . Finally, we present an introduction to the potential therapeutic application of most recent pharmaceuticals including miRNAs in prostate cancer that specifically target the transactivation function of the AR at post‐transcriptional stages.